Correlation Between Guangzhou Boji and Cabio Biotech

Can any of the company-specific risk be diversified away by investing in both Guangzhou Boji and Cabio Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guangzhou Boji and Cabio Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Guangzhou Boji Medical and Cabio Biotech Wuhan, you can compare the effects of market volatilities on Guangzhou Boji and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guangzhou Boji with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guangzhou Boji and Cabio Biotech.

Diversification Opportunities for Guangzhou Boji and Cabio Biotech

0.86

Correlation Coefficient

Guangzhou Boji  Cabio Biotech

Very poor diversification

The 3 months correlation between Guangzhou and Cabio is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Guangzhou Boji Medical and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and Guangzhou Boji is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guangzhou Boji Medical are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of Guangzhou Boji i.e., Guangzhou Boji and Cabio Biotech go up and down completely randomly.

Pair Corralation between Guangzhou Boji and Cabio Biotech

Assuming the 90 days trading horizon Guangzhou Boji is expected to generate 3.47 times less return on investment than Cabio Biotech. But when comparing it to its historical volatility, Guangzhou Boji Medical is 1.38 times less risky than Cabio Biotech. It trades about 0.05 of its potential returns per unit of risk. Cabio Biotech Wuhan is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,932  in Cabio Biotech Wuhan on December 25, 2024 and sell it today you would earn a total of  506.00  from holding Cabio Biotech Wuhan or generate 26.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Guangzhou Boji Medical  vs.  Cabio Biotech Wuhan

Guangzhou Boji Medical

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Guangzhou Boji Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Guangzhou Boji may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Cabio Biotech Wuhan

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cabio Biotech Wuhan are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cabio Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Guangzhou Boji and Cabio Biotech

The main advantage of trading using opposite Guangzhou Boji and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guangzhou Boji position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.

The idea behind Guangzhou Boji Medical and Cabio Biotech Wuhan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.